Business Model Breakdown
How Nutrien Ltd Makes Money
NTR
Market Cap
$24.0B
Annual Revenue
$14.0B
Profit Margin
6.0%
Employees
25,500
The Short Version
Nutrien is the world's largest provider of crop inputs and services, playing a critical role in supporting global food production. The company mines and produces essential crop nutrients like potash, nitrogen, and phosphate, which it then sells directly to farmers through its vast retail network, as well as to industrial customers. It also offers a range of agronomic services and other agricultural products, enabling farmers to enhance crop yields and operational efficiency.
Where the Revenue Comes From
Potash sales (major segment, specific percentage not provided)
Nitrogen sales (major segment, specific percentage not provided)
Phosphate sales (major segment, specific percentage not provided)
Retail sales of crop inputs, services, and merchandise (major segment, specific percentage not provided)
Who buys: Global farmers, agricultural cooperatives, and industrial clients.
Why It Works (Competitive Advantages)
- ✔Vast, geographically diverse production assets (potash, nitrogen, phosphate)
- ✔Extensive global retail distribution network (2,000+ sites)
- ✔Significant scale providing cost efficiencies and purchasing power
Economic Moat: Narrow (Cost Advantages, Efficient Scale, Intangible Assets/IP (Brand Power and established customer relationships))
What Our Analysis Says
DVR Score as of April 8, 2026
Nutrien Ltd. remains a mature, large-cap leader in the essential agricultural inputs sector, boasting significant competitive advantages from its scale, diverse asset base, and integrated retail network. Recent Q4 2025 earnings missed estimates, and while the company expanded share buybacks and increased its dividend by 1%, these actions reflect a focus on shareholder returns and stability rather than hyper-growth. With a current market capitalization of $50.73B in a cyclical, established industry, there are no material changes or strategic pivots indicated by the latest market intelligence (Mar-Apr 2026 filings, earnings misses, analyst consensus) that suggest a realistic pathway to 10x growth within 3-5 years. The company's financial health is generally solid, but its growth trajectory, capital allocation strategy, and market opportunity do not align with high-risk, high-reward exponential upside. Therefore, its score for 10x potential remains consistently very low, reflecting its position as a stable, rather than a hyper-growth, investment.